Macrophage membrane-coated Eucommia ulmoides polysaccharides-loaded PLGA nanoparticles as an effective antigen-targeted delivery system
Source abstract
Abstract
Polysaccharides derived from Eucommia ulmoides leaves have immune-regulating, hypoglycemic, anti-tumor, and other beneficial functions. As a drug delivery system, polylactic-glycolic acid copolymer (PLGA) offers advantages like immunogenicity enhancement, improved drug absorption, and increased drug bioavailability. Currently, macrophage membranes are successfully employed in biomimetic nanomaterials to enhance drug utilization and extend drug administration time in the body, exhibiting good immunogenicity and organ targeting. In this study, we developed biomimetic PsEUL PLGA nanoparticles (NPs) coated with macrophage membrane (MM-PPsEUL) and examined their immune activity in vitro and in vivo. In vitro , MM-PPsEUL increased the phagocytic efficiency of macrophages without affecting their activity. In vivo , MM-PPsEUL significantly elevated the immune organ index of mice and upregulated the level of ovalbumin-specific IgG antibodies in serum. Simultaneously, it increased the expressions of cytokines IFN-γ and IL-4, as well as the levels of TLR4, MyD88, TRAF6, and NF-κB p65 proteins in mice spleen. MM-PPsEUL also exhibited a targeting effect on inguinal lymph nodes and slowed down the release rate of antigens, thereby inducing a prolonged immune response. In summary, MM-PPsEUL provides sustained release capabilities and can induce both humoral and cellular immune responses. This makes MM-PPsEUL NPs a promising antigen-targeted delivery system.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Eucommia ulmoides Oliv.: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine10.1016/j.jep.2013.11.023 ↗
2. Chemical constituents, biological functions and pharmacological effects for comprehensive utilization of Eucommia ulmoides Oliver10.1016/j.fshw.2019.03.013 ↗
3. Optimized microwave extraction, characterization and antioxidant capacity of biological polysaccharides from Eucommia ulmoides Oliver leaf10.1038/s41598-018-24957-0 ↗
4. Fabrication of strontium Eucommia ulmoides polysaccharides and in vitro evaluation of their osteoimmunomodulatory property10.1016/j.ijbiomac.2019.08.145 ↗
5. Eucommia ulmoides Leaf Polysaccharide in Conjugation with Ovalbumin Act as Delivery System Can Improve Immune Response10.3390/pharmaceutics13091384 ↗
6. Cancer nanomedicine: progress, challenges and opportunities10.1038/nrc.2016.108 ↗
7. Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment10.1016/j.apsb.2015.03.001 ↗
8. Targeted and effective photodynamic therapy for cancer using functionalized nanomaterials10.1016/j.apsb.2016.01.007 ↗
9. Development of PLGA-coated beta-TCP scaffolds containing VEGF for bone tissue engineering10.1016/j.msec.2016.07.011 ↗
10. Formulations for modulation of protein release from large-size PLGA microparticles for tissue engineering10.1016/j.msec.2014.11.003 ↗
11. Gemcitabine loaded biodegradable PLGA nanospheres for in vitro pancreatic cancer therapy10.1016/j.msec.2014.11.027 ↗
12. Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier10.3390/polym3031377 ↗
13. Current advances in research and clinical applications of PLGA-based nanotechnology10.1586/erm.09.15 ↗
14. Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics10.1016/j.msec.2017.12.036 ↗
15. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery10.1016/j.jconrel.2004.09.014 ↗
16. Alhagi honey polysaccharides encapsulated into PLGA nanoparticle-based pickering emulsion as a novel adjuvant to induce strong and long-lasting immune responses10.1016/j.ijbiomac.2022.01.020 ↗
17. Cell membrane coated nanoparticles: next-generation therapeutics10.2217/nnm-2017-0225 ↗
18. Ligand-modified cell membrane enables the targeted delivery of drug Nanocrystals to Glioma10.1021/acsnano.9b00661 ↗
19. Recent advancements in biocompatible inorganic nanoparticles towards biomedical applications10.1039/C7BM01020F ↗
20. Recent advances in cell membrane-camouflaged nanoparticles for cancer phototherapy
21. Recent trends in cell membrane-cloaked nanoparticles for therapeutic applications10.1016/j.ymeth.2019.12.004 ↗
22. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases10.1186/2050-7771-2-1 ↗
23. Macrophage Cell Membrane-Cloaked Nanoplatforms for Biomedical Applications10.1002/smtd.202200289 ↗
24. Macrophage membrane coated nanoparticles: a biomimetic approach for enhanced and targeted delivery10.1039/D1BM01664D ↗
25. Macrophage-membrane-coated nanoparticles for tumor-targeted chemotherapy10.1021/acs.nanolett.7b05263 ↗
26. Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications10.7150/thno.47841 ↗
27. Phagocyte-membrane-coated and laser-responsive nanoparticles control primary and metastatic cancer by inducing anti-tumor immunity10.1016/j.biomaterials.2020.120159 ↗
28. Bacteria activated-macrophage membrane-coated tough nanocomposite hydrogel with targeted photothermal antibacterial ability for infected wound healing
29. An electroporation strategy to synthesize the membrane-coated nanoparticles for enhanced anti-inflammation therapy in bone infection10.7150/thno.48407 ↗
30. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform10.1073/pnas.1106634108 ↗
31. Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics10.1002/ctm2.292 ↗
32. White blood cell membrane-coated nanoparticles: recent development and medical applications10.1002/adhm.202101349 ↗
33. Nanoparticles coated with cell membranes for biomedical applications
34. PLGA-based nanoparticles as cancer drug delivery systems10.7314/APJCP.2014.15.2.517 ↗
35. Structure and function of the immune system in the spleen10.1126/sciimmunol.aau6085 ↗
36. T helper lymphocyte subsets and plasticity in autoimmunity and cancer: an overview10.1155/2015/327470 ↗
37. Carbohydrate-based nanocarriers and their application to target macrophages and deliver antimicrobial agents10.1016/j.addr.2019.09.002 ↗
38. Structure and antitumor and immunomodulatory activities of a water-soluble polysaccharide from Dimocarpus longan pulp10.3390/ijms15035140 ↗
39. Effector T cell plasticity: flexibility in the face of changing circumstances10.1038/ni.1899 ↗
40. History and principles of vaccination10.1016/j.rmr.2018.02.015 ↗
41. Heterogeneity in the differentiation and function of CD8(+) T cells10.1007/s00005-014-0293-y ↗
42. Mechanisms and consequences of dendritic cell migration10.1016/j.immuni.2008.08.006 ↗
43. Simple nanoliposomes encapsulating Lycium barbarum polysaccharides as adjuvants improve humoral and cellular immunity in mice10.2147/IJN.S136820 ↗
44. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases10.1016/j.cyto.2014.09.011 ↗
45. Astragalus polysaccharides exerts immunomodulatory effects via TLR4-mediated MyD88-dependent signaling pathway in vitro and in vivo10.1038/srep44822 ↗
46. Polysaccharide of Atractylodes macrocephala Koidz enhances cytokine secretion by stimulating the TLR4-MyD88-NF-kappaB signaling pathway in the mouse spleen10.1089/jmf.2018.4393 ↗
47. An aluminum adjuvant-integrated nano-MOF as antigen delivery system to induce strong humoral and cellular immune responses10.1016/j.jconrel.2019.02.035 ↗